Latest Johnson & Johnson News & Updates

See the latest news and media coverage for J&J. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Johnson & Johnson (J&J)

Multinational healthcare company

jnj.com
Headquarters
New Brunswick, United States
Company type
Public company
Number of employees
100,000+

Last updated

Latest news about Johnson & Johnson (J&J)

In short: J&J reported strong Q1 2026 sales of $24.1 billion, raised its full-year guidance, and faced legal developments regarding its talcum powder cases.

Company announcements

  • J&J

    J&J announces JNJ-4804 Phase 2b data

    JNJ-4804 shows superior clinical remission and endoscopic response in refractory UC and CD patients vs comparators. Supports Phase 3 advancement.

  • J&J

    J&J announces TREMFYA efficacy in perianal fistulizing Crohn’s

    Phase 3 FUZION study shows 27-28% combined fistula remission at Week 24 vs 10% placebo. First such trial in 20 years, presented at DDW 2026.

  • J&J

    J&J announces pivotal clinical study results

    Data show OTTAVA met primary safety and performance endpoints in a 30‑patient Roux‑en‑Y study. Findings supported a De Novo FDA application.

  • J&J

    J&J announces CAPLYTA shows greatest efficacy in MDD meta-analysis

    CAPLYTA ranked highest across four efficacy measures and showed no weight gain versus placebo plus ADT in network meta-analysis presented at NEI Congress.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about J&J

Track J&J and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.